The move followed a year-long investigation into Xu and escalated a broader conflict between European officials and US tech companies over social media regulation.
Source link
Merck (MRK) Q4 2025 Earnings
Merck Fourth-quarter earnings and revenue reported Tuesday beat expectations for strong demand for its cancer immunotherapy Keytruda and some new products. But the company posted a tepid outlook for 2026,…







